STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
Authors
Michael Korenfeld (ORCID: https://orcid.org/0000-0003-1804-5525)
Janet K. Cheetham (ORCID: https://orcid.org/0000-0003-4603-5375)
Dana Tomčíková
Maria Hurcikova
Kay Tatsuoka
Marek Kacerik
on behalf of the STAR Study Investigators
Institutions
National Institute of Cardiovascular Diseases (SK)
Vysoká škola manažmentu, City University of Seattle (SK)
STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
Michael Korenfeld, Janet K. Cheetham, Dana Tomčíková, Maria Hurcikova et al.
Journal
Ophthalmology and Therapy
Topics
Ophthalmology and Visual Impairment Studies
article
STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
Michael Korenfeld, Janet K. Cheetham, Dana Tomčíková, Maria Hurcikova, Kay Tatsuoka, Marek Kacerik, on behalf of the STAR Study Investigators
article en
Abstract
No abstract available for this paper.
Publication Tag
Ophthalmology and Therapy
Institutions
National Institute of Cardiovascular Diseases (SK), Vysoká škola manažmentu, City University of Seattle (SK), Santen (United States) (US), Laguna Research (US), Comprehensive Eye Care (US), Nemocnice Třebíč (CZ)